Neurocrine Biosciences (NBIX) Other Non-Current Assets (2010 - 2026)
Neurocrine Biosciences' Other Non-Current Assets was $59.3 million in Q2 2026, up 174.5% from $21.6 million a year earlier but down 19.4% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Other Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Other Non-Current Assets at Neurocrine Biosciences came in at $48.7 million, down 6.3% from FY2024.
- Other Non-Current Assets shows a five-year compound annual growth rate of 50.1% (FY2020 to FY2025).
- In earlier years, Other Non-Current Assets was $52 million in FY2024 (+4.8%), $49.6 million in FY2023 (+98.4%), $25 million in FY2022 (+468.2%) and $4.4 million in FY2021 (-31.3%).
- Quarterly Other Non-Current Assets has moved between $3.2 million (Q3 2021) and $73.6 million (Q1 2026) over five years.
- Compared with a year earlier, Other Non-Current Assets was higher in four of the last eight quarters, with growth averaging 49.7%.
- The best year-over-year quarter for Other Non-Current Assets over five years was Q4 2022 (growth of 468.2%); the worst was Q1 2025 (a decline of 69.9%).
- Per Business Quant data, NBIX's Other Non-Current Assets in the three quarters before Q2 2026 was $73.6 million (Q1 2026), $48.7 million (Q4 2025) and $20.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Neurocrine Biosciences | 14.41 Bn | 10.11 Bn | 935.80 Mn | 59.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59.30 Mn |
| Mar 31, 2026 | 73.60 Mn |
| Dec 31, 2025 | 48.70 Mn |
| Sep 30, 2025 | 20.30 Mn |
| Jun 30, 2025 | 21.60 Mn |
| Mar 31, 2025 | 15.30 Mn |
| Dec 31, 2024 | 52.00 Mn |
| Sep 30, 2024 | 61.60 Mn |
| Jun 30, 2024 | 57.80 Mn |
| Mar 31, 2024 | 50.90 Mn |
| Dec 31, 2023 | 49.60 Mn |
| Sep 30, 2023 | 43.10 Mn |
| Jun 30, 2023 | 35.90 Mn |
| Mar 31, 2023 | 24.90 Mn |
| Dec 31, 2022 | 25.00 Mn |
| Sep 30, 2022 | 10.50 Mn |
| Jun 30, 2022 | 10.00 Mn |
| Mar 31, 2022 | 10.10 Mn |
| Dec 31, 2021 | 4.40 Mn |
| Sep 30, 2021 | 3.20 Mn |
API Access
Neurocrine Biosciences Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();